W. Reid Litchfield

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Thomas R. Pieber, Bruce W. Bode, Young Min Cho et al. · The Lancet Diabetes & Endocrinology · 2019 · 274 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Effect of Activation and Inhibition of the Renin-Angiotensin System on Plasma PAI-1

Nancy J. Brown, Gordon H. Williams, W. Reid Litchfield et al. · Hypertension · 1998 · 270 citations · Full text

Medicine, Cardiology, Pharmacology +13

Intracranial Aneurysm and Hemorrhagic Stroke in Glucocorticoid-remediable Aldosteronism

W. Reid Litchfield, Bruce F. Anderson, Ruediger J. Weiss et al. · Hypertension · 1998 · 198 citations

Medicine, Internal Medicine, Neurology +12

Increased Urinary Free Cortisol

W. Reid Litchfield, Steven C. Hunt, Xavier Jeunemaı̂tre et al. · Hypertension · 1998 · 97 citations · Full text

Medicine, Endocrinology, Physiology +11

Evaluation of the Dexamethasone Suppression Test for the Diagnosis of Glucocorticoid-Remediable Aldosteronism1

W. Reid Litchfield, Maria I. New, Caroline Coolidge et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 86 citations · Full text

Life Sciences, Endocrinology, Genetics +11